2007
DOI: 10.1186/1742-6405-4-15
|View full text |Cite
|
Sign up to set email alerts
|

Protease inhibitor associated mutations compromise the efficacy of therapy in human immunodeficiency virus – 1 (HIV-1) infected pediatric patients: a cross-sectional study

Abstract: Background: Although the introduction of combined therapy with reverse transcriptase and protease inhibitors has resulted in considerable decrease in HIV related mortality; it has also induced the development of multiple drug-resistant HIV-1 variants.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
1

Year Published

2009
2009
2014
2014

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 40 publications
0
0
1
Order By: Relevance
“…We found that the immunologic response in the majority of patients was in the persistent nonsuppression category and was not associated with adherence patterns. Previously in our cross-sectional study, 21 we had also not found an association between the high level of virus production and severity of CD4 count depletion in children with HIV. Resino et al 22 showed that VL suppression is not necessary for recovery of CD4 counts.…”
Section: Discussioncontrasting
confidence: 59%
“…We found that the immunologic response in the majority of patients was in the persistent nonsuppression category and was not associated with adherence patterns. Previously in our cross-sectional study, 21 we had also not found an association between the high level of virus production and severity of CD4 count depletion in children with HIV. Resino et al 22 showed that VL suppression is not necessary for recovery of CD4 counts.…”
Section: Discussioncontrasting
confidence: 59%